top of page
  • Writer's pictureARQon

Saudi Arabia SFDA: New Online System GHAD Replacing Old System Hits The Local Registrants

Updated: Jan 30, 2020

Announcement made by Saudi Arabia SFDA in August hits the local registrants. In-country representatives as SFDA are closing all the current medical devices registration systems and replace them with a Unified Electronic System (GHAD).

Ghad allows an unified registration platform on the Medical Device Marketing Authorization (MDMA), Medical Device National Registry (MDNR), Saudi Authorized Representative and other applications to SFDA.

SFDA advised that registered establishments to register and open a new account on the Ghad System, starting from 10 November 2019. All the existing and pending applications in the old system will have to be transferred to Ghad by the applicant. Applicant action is important to ensure that they maintain copies of the current applications and documents from the old SFDA system before all these old systems closed, before 26 December 2019.

SFDA Technical Files & Saudi Arabia regulation

More technical files will be required from the manufacturers to provide evidence of compliance to a certain route.

The manufacturer needs to provide the following:

  1. The Technical File document in which the intended use and clinical benefits are stated to each device.

  2. Post-Market Surveillance (PMS) plan and report for each device.

  3. Risk management report and plan

  4. Classification and compliance check list.

  5. Clinical evaluation report

  6. Post marketing clinical follow up

Click here for the new regulations (MDS-G5).

SFDA product approval validity and fee

The expiry date of the product approvals used to depend on the expiry of the manufacturer certificates and maximum of 3 years. However, the new system will issue an approval for 3 years consistently, and fees for review will depend on the number of items in the application.

Click here for the new fees by SFDA (SFDA-MD36466).

Source: SFDA

Contact info@arqon.com


793 views0 comments

Recent Posts

See All

Asia, Africa & Middle East - Aug 2019

Australia: 2019 fees and charges released by the Therapeutic Goods Administration Australia: Conformity assessment standards for medical device QMSs Australia: TGA will no longer send out annual repor

Asia, Africa & Middle East - Dec 2018

AHWP: Guidance on labelling for in vitro diagnostic medical devices Australia: Application fee change for export only medical devices Australia: Updated requirements specified for preliminary assessme

Drug - Dec 2018

Australia - Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2018 Brazil - Questions and Answers: Resolution RDC 242/2018 on Registration of Specific Medicinal Products Canada - Form:

bottom of page